World’s First 4-Wavelength Therapy Laser Launches to Veterinary and Human Medical Market
First FDA cleared in 2002, therapeutic lasers are the fastest growing modality in both the Veterinary and Human Medical markets. They are gaining popularity for their ease of use, cost effectiveness, and unparalleled clinical efficacy across a broad range of therapeutic applications for pain management and wound healing. K-LaserUSA has been at the top of this industry since 2005, and has continued to evolve the technology to fit the ever-growing research of laser biostimulation. Today, the bar has been set many steps higher as K-LaserUSA introduces the Cube series laser, the world’s first 4-wavelength therapeutic laser.
Laser light of different wavelengths influences different biological targets in the body. To this point, engineering difficulties have limited clinical efficacy of including multiple-wavelength light sources within compact, practical equipment. Current state-of-the-art therapy lasers can produce two independent wavelengths strategically selected in the part of the light spectrum where the body is most transparent (for highest penetration capabilities) and where the absorption of useful biological enzymes is high.
K-LaserUSA has not simply taken the next step, but has pioneered a full paradigm shift towards robust laser technology that combines high-level research with engineering advancements to make this already successful modality more compact, intuitive, powerful, and far-reaching than any of its predecessors.
“We know that different tissue-types in our bodies respond better to different laser parameters,” explains Bryan Stephens, PhD the Director of Research and Development for K-LaserUSA, “but until now, our treatment options have been limited by how much we can fit into one device and how precisely we could control the temperature and efficiency of our diodes. From a hardware perspective, the optic coupling, cooling mechanisms, battery life, and memory capacity of the Cube are head and shoulders more advanced than any laser out there, including our current model.”
High-level technology is useless unless it is easy to use by the clinician. “We started from scratch and worked hard to organize the Cube’s software based on what doctors really know about the patient and condition and combined everything we have learned from the current literature to narrow down the optimal parameters appropriate for that treatment” says Dr. Phil Harrington, CMLSO K-Laser’s Clinical Education Manager.
Whether you are a limping athlete, car accident survivor or owner of an aching Rottweiler, K-LaserUSA has just made the road to recovery quicker and easier without the liver spotting, kidney straining, and dependence insisting pharmaceuticals that your desperation has demanded. Ask your doctor how the K-Laser can get you back to health.
“We have been working on this project for nearly two years, and want to thank all of our doctors, engineers, and staff who have been instrumental in making this a reality. There is no other class IV therapy laser available on the market today that can match the capabilities of the Cube Series.” Dr. Richard Albright, President of K-LaserUSA.
Built upon a solid foundation of European research and development, K-LaserUSA has earned worldwide recognition for its therapy and treatment solutions. The K-LaserUSA development team is dedicated to offering the most advanced technologies to our clients, with a never-ending dedication to innovation.
# # #
For more information on the Cube Series from K-LaserUSA, contact Dr. Richard Albright at 866-595-7749 or email@example.com.